| Deler fremragende | 4,285,570 shares |
| Insideraktier | 5.117.068 shares |
| Total Insiders | 32 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Soligenix, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Robert N Brey | 10.000 | ||
| Keith L Brownlie Director - [D] | 50.000 | 3.659 | |
| Marco Maria Brughera Director - [D] | 2.750 | 177 | |
| Cyrille F Buhrman Director - [D] | 4.900.020 | 4.900.020 | |
| Paolo Cavazza - | 293.510 | 18.936 | |
| Enrico Cavazza - | 293.510 | 18.936 | |
| Francesca Cavazza - | 293.510 | 18.936 | |
| Preta Martina Cavazza - | 293.510 | 18.936 | |
| Silvia Cavazza - | 293.510 | 18.936 | |
| Cote Timothy R. Director - [D] | 50.634 | 3.165 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Oreola Donini | 70.000 | ||
|
Corp Plc Elan
10% Owner -
|
162.600 | 162.600 | |
|
Elan International Services Ltd
10% Owner -
|
162.600 | 162.600 | |
|
Elan Pharmaceutical Investments Ii Ltd
10% Owner -
|
1.468.900 | 1.468.900 | |
|
Elan Pharmaceutical Investments Ltd
10% Owner -
|
162.600 | 162.600 | |
| SPA Essetifin - | 293.510 | 18.936 | |
| Guarino Jonathan L. Senior Vice President and CFO - [O] | 10.000 | 645 | |
| Kevin Horgan | 85.000 | ||
|
Corp Intrexon
10% Owner -
|
85.397 | 5.509 | |
|
Randal J Kirk
10% Owner -
|
85.397 | 5.509 | |
| Karen R Krumeich SVP and CFO - [O] | 26.000 | 1.902 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Anthony Gregg Lapointe Director - [D] | 73.781 | 5.399 | |
|
Leadiant Biosciences, Inc.
10% Owner -
|
293.510 | 18.936 | |
| Parks Diane L. Director - [D] | 14.940 | 964 | |
|
Pearson Mark E.
Director, 10% Owner -
[D]
|
78.338 | 5.054 | |
| Rubin Robert J. Director - [D] | 4.385 | 283 | |
| Christopher J Schaber CHAIRMAN, CEO AND PRESIDENT, Director - [D] [O] | 90.095 | 5.813 | |
|
Sigma Tau International Sa
10% Owner -
|
2.711.393 | 3.967.889 | |
|
Sigma-Tau America S.A.
10% Owner -
|
2.711.393 | 3.967.889 | |
| Richard Straube SENIOR VICE PRESIDENT AND CMO - [O] | 8.000 | 516 | |
| Joseph Michael Warusz VP of Finance/Acting CFO - [O] | 12.955 | 948 | |
| Jerome B Zeldis Director - [D] | 22.917 | 1.479 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SNGX / Soligenix, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SNGX / Soligenix, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-05 | 3 | Cote Timothy R. Silk Road Therapeutics, Inc. | SNGX | Common Stock | I | 25.317 | ||||||||
| 2022-05-18 | 2022-05-18 | 4 | Straube Richard | SNGX | COMMON STOCK | D | 0,5000 | 8.000 | 4 | 8.000 | ||||
| 2022-05-18 | 2022-05-18 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,4433 | 20.000 | 9 | 90.095 | ||||
| 2022-01-21 | 2022-01-21 | 4 | Guarino Jonathan L. | SNGX | Option (Right to Buy) | D | 0,78 | 50.000 | 50.000 | |||||
| 2022-01-21 | 2022-01-21 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,69 | 47.315 | 47.315 | |||||
| 2022-01-04 | 2022-01-03 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,69 | 60.000 | 60.000 | |||||
| 2021-12-20 | 2021-12-17 | 4 | SCHABER CHRISTOPHER J | SNGX | COMMON STOCK | D | 0,7399 | 7.000 | 5 | 70.095 | ||||
| 2021-12-15 | 2021-12-15 | 4 | Guarino Jonathan L. | SNGX | COMMON STOCK | D | 0,7000 | 1.000 | 1 | 11.000 | ||||
| 2021-12-15 | 2021-12-14 | 4 | Guarino Jonathan L. | SNGX | COMMON STOCK | D | 0,7119 | 10.000 | 7 | 10.000 | ||||
| 2021-12-14 | 2021-12-14 | 4 | SCHABER CHRISTOPHER J | SNGX | COMMON STOCK | D | 0,7269 | 10.000 | 7 | 63.095 | ||||
| 2021-12-10 | 2021-12-09 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,78 | 60.000 | 60.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 0,78 | 50.000 | 50.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 0,78 | 70.000 | 70.000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 0,78 | 40.000 | 40.000 | |||||
| 2021-09-24 | 2021-09-23 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-09-24 | 2021-09-23 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,03 | 29.126 | 29.126 | |||||
| 2021-05-18 | 2021-05-14 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9002 | -3.000 | -3 | 22.917 | ||||
| 2021-05-18 | 2021-05-14 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,8880 | 3.000 | 3 | 25.917 | ||||
| 2021-01-04 | 2021-01-04 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,28 | 60.000 | 60.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,34 | 70.000 | 70.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,34 | 60.000 | 60.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,34 | 40.000 | 40.000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 2,34 | 40.000 | 40.000 | |||||
| 2020-09-18 | 2020-09-16 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-09-18 | 2020-09-16 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,97 | 15.228 | 15.228 | |||||
| 2020-06-19 | 2020-06-18 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 1,76 | 13.500 | 13.500 | |||||
| 2020-01-02 | 2020-01-02 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,45 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 1,24 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 1,24 | 10.000 | 10.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,24 | 60.000 | 60.000 | |||||
| 2019-12-13 | 2019-12-12 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 1,24 | 30.000 | 30.000 | |||||
| 2019-11-19 | 2019-11-19 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,9300 | 10.770 | 10 | 53.095 | ||||
| 2019-11-19 | 2019-11-19 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9250 | 2.000 | 2 | 22.917 | ||||
| 2019-09-23 | 2019-09-23 | 4 | Parks Diane L. | SNGX | Common Stock | D | 0,9284 | 14.940 | 14 | 14.940 | ||||
| 2019-09-23 | 2019-09-19 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,9350 | 4.000 | 4 | 20.917 | ||||
| 2019-09-11 | 2019-09-09 | 4 | Guarino Jonathan L. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2019-09-10 | 2019-09-06 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-09-10 | 2019-09-06 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,97 | 30.928 | 30.928 | |||||
| 2019-07-10 | 2019-06-28 | 4 | Pearson Mark E. | SNGX | Common Stock | I | 0,7100 | 78.338 | 56 | 78.338 | ||||
| 2019-07-08 | 2019-07-08 | 4 | Parks Diane L. | SNGX | Stock Option (Right to Buy) | D | 0,86 | 1.500 | 1.500 | |||||
| 2019-04-22 | 2019-04-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,7154 | 5.000 | 4 | 42.325 | ||||
| 2019-04-22 | 2019-04-22 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,7274 | 10.000 | 7 | 16.917 | ||||
| 2019-01-04 | 2019-01-02 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,96 | 60.000 | 60.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,97 | 60.000 | 60.000 | |||||
| 2018-12-14 | 2018-12-13 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 0,97 | 40.000 | 40.000 | |||||
| 2018-10-18 | 2018-10-18 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,1698 | 8.700 | 10 | 37.325 | ||||
| 2018-10-17 | 2018-10-17 | 4 | Pearson Mark E. | SNGX | Common Stock | D | 1,1600 | 170.000 | 197 | 2.500.000 | ||||
| 2018-09-28 | 2018-09-27 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-09-28 | 2018-09-27 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,67 | 17.964 | 17.964 | |||||
| 2018-08-22 | 2018-08-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,4198 | 3.530 | 5 | 28.625 | ||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 3 | Pearson Mark E. | SNGX | COMMON STOCK | D | 4.660.000 | ||||||||
| 2018-07-25 | 2018-07-20 | 4 | Pearson Mark E. | SNGX | Stock Option (Right to Buy) | D | 1,22 | 1.500 | 1.500 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,01 | 80.000 | 80.000 | |||||
| 2017-12-11 | 2017-12-07 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,01 | 35.000 | 35.000 | |||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 16.416 | 35 | 293.510 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -16.416 | -35 | 0 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 5.954 | 13 | 277.094 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -5.954 | -13 | 0 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA | SNGX | Common Stock | D | 2,1200 | 271.140 | 575 | 271.140 | ||||
| 2017-12-01 | 2017-11-29 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 2,1200 | -271.140 | -575 | 0 | ||||
| 2017-06-12 | 2017-06-08 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,29 | 13.100 | 13.100 | |||||
| 2017-05-08 | 2017-05-08 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,5400 | -1.881 | -5 | 85.397 | ||||
| 2017-05-08 | 2017-05-08 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,5400 | -9.695 | -25 | 440.418 | ||||
| 2017-05-08 | 2017-05-05 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,7000 | -13.893 | -38 | 87.278 | ||||
| 2017-05-08 | 2017-05-05 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,7000 | -71.607 | -193 | 450.113 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Warrant to Purchase Common Stock | I | 0,80 | -250.000 | 0 | |||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by Intrexon | SNGX | Common Stock | I | 2,9700 | -2.278 | -7 | 101.171 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 2,9700 | -11.739 | -35 | 521.720 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 4,0100 | -49.875 | -200 | 533.459 | ||||
| 2017-05-08 | 2017-05-04 | 4 | KIRK RANDAL J by NRM VII Holdings | SNGX | Common Stock | I | 0,8000 | 250.000 | 200 | 583.334 | ||||
| 2017-04-04 | 2017-03-31 | 4 | Donini Oreola | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 2,67 | 50.000 | 50.000 | |||||
| 2017-04-04 | 2017-03-31 | 4 | Straube Richard | SNGX | Option (Right to Buy) | D | 2,67 | 20.000 | 20.000 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Brughera Marco Maria | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 2.500 | 0 | 2.500 | |||
| 2016-12-20 | 2016-12-16 | 4 | Brughera Marco Maria | SNGX | Common Stock | D | 3,1599 | 2.000 | 6 | 2.750 | ||||
| 2016-12-20 | 2016-12-16 | 4 | RUBIN ROBERT J. | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 3.956 | 0 | 3.956 | |||
| 2016-12-20 | 2016-12-16 | 4 | RUBIN ROBERT J. | SNGX | Common Stock | D | 3,1599 | 3.165 | 10 | 4.385 | ||||
| 2016-12-20 | 2016-12-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 3,95 | 0,0001 | 19.755 | 0 | 19.755 | |||
| 2016-12-20 | 2016-12-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 3,1599 | 15.804 | 50 | 25.095 | ||||
| 2016-06-22 | 3 | Krumeich Karen R | SNGX | Common Stock | D | 26.000 | ||||||||
| 2016-06-22 | 3 | Krumeich Karen R | SNGX | Common Stock | D | 26.000 | ||||||||
| 2016-06-22 | 2016-06-16 | 4 | Krumeich Karen R | SNGX | Option (Right to Buy) | D | 0,74 | 100.000 | 100.000 | |||||
| 2016-06-20 | 2016-06-16 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 0,74 | 40.541 | 40.541 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Donini Oreola | SNGX | Stock Option (Right to Buy) | D | 1,13 | 70.000 | 70.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 1,13 | 70.000 | 70.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 1,13 | 55.000 | 55.000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,13 | 140.000 | 140.000 | |||||
| 2015-12-23 | 2015-12-23 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 1,2700 | 2.500 | 3 | 69.166 | ||||
| 2015-12-23 | 2015-12-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,2878 | 10.000 | 13 | 85.761 | ||||
| 2015-08-31 | 2015-08-31 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Common Stock Warrant | D | 0,30 | -25.000 | 0 | |||||
| 2015-08-31 | 2015-08-31 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Common Stock | D | 0,3000 | 25.000 | 8 | 73.781 | ||||
| 2015-07-01 | 2015-07-01 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 0,61 | -7.143 | 0 | |||||
| 2015-07-01 | 2015-07-01 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,6100 | 7.143 | 4 | 82.904 | ||||
| 2015-06-19 | 2015-06-18 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-06-19 | 2015-06-18 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 1,51 | 19.868 | 19.868 | |||||
| 2015-04-09 | 2015-04-09 | 4 | Brownlie Keith L | SNGX | Common Stock Warrant | D | 0,61 | -14.286 | 0 | |||||
| 2015-04-09 | 2015-04-09 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 0,6100 | 14.286 | 9 | 50.000 | ||||
| 2015-04-09 | 2015-04-09 | 4 | ZELDIS JEROME B | SNGX | Common Stock Warrant | D | 0,61 | -17.857 | 0 | |||||
| 2015-04-09 | 2015-04-09 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,6100 | 17.857 | 11 | 66.666 | ||||
| 2014-12-24 | 2014-12-24 | 4 | Warusz Joseph Michael | SNGX | Common Stock Warrant | D | 1,48 | 4.959 | 4.959 | |||||
| 2014-12-24 | 2014-12-22 | 4 | Warusz Joseph Michael | SNGX | Common Stock | D | 1,2100 | 8.265 | 10 | 12.955 | ||||
| 2014-12-24 | 2014-12-24 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrant | D | 1,48 | 4.959 | 4.959 | |||||
| 2014-12-24 | 2014-12-22 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,2100 | 8.265 | 10 | 75.761 | ||||
| 2014-12-08 | 2014-12-04 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 1,50 | 45.000 | 45.000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 1,50 | 50.000 | 50.000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 1,50 | 100.000 | 100.000 | |||||
| 2014-08-05 | 2014-08-05 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,01 | -7.500 | 7.500 | |||||
| 2014-08-05 | 2014-08-05 | 4 | Brughera Marco Maria | SNGX | Common Stock | D | 2,0100 | 7.500 | 15 | 7.500 | ||||
| 2014-06-20 | 2014-06-19 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-06-20 | 2014-06-19 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,19 | 13.669 | 13.669 | |||||
| 2014-05-19 | 2014-05-19 | 4 | Warusz Joseph Michael | SNGX | Option (Right to Buy) | D | 0,64 | -4.690 | 25.310 | |||||
| 2014-05-19 | 2014-05-19 | 4 | Warusz Joseph Michael | SNGX | Common Stock | D | 0,6400 | 4.690 | 3 | 4.690 | ||||
| 2014-05-16 | 2014-05-14 | 4 | Brownlie Keith L | SNGX | Option (Right to Buy) | D | 0,30 | -16.667 | 8.333 | |||||
| 2014-05-16 | 2014-05-14 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 0,3000 | 16.667 | 5 | 35.714 | ||||
| 2014-05-14 | 2014-05-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Option (Right to Buy) | D | 0,64 | -7.815 | 112.185 | |||||
| 2014-05-14 | 2014-05-13 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,6400 | 7.815 | 5 | 67.496 | ||||
| 2014-01-08 | 2014-01-06 | 4 | Straube Richard | SNGX | Stock Option (Right to Buy) | D | 2,01 | 100.000 | 100.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | BREY ROBERT N | SNGX | Stock Option (Right to Buy) | D | 2,01 | 10.000 | 10.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | Brughera Marco Maria | SNGX | Stock Option (Right to Buy) | D | 2,01 | 15.000 | 15.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | SCHABER CHRISTOPHER J | SNGX | Stock Option (Right to Buy) | D | 2,01 | 100.000 | 100.000 | |||||
| 2013-12-09 | 2013-12-05 | 4 | Warusz Joseph Michael | SNGX | Stock Option (Right to Buy) | D | 2,01 | 45.000 | 45.000 | |||||
| 2013-10-01 | 2013-09-27 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-10-01 | 2013-09-27 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 2,26 | 13.275 | 13.275 | |||||
| 2013-09-27 | 2013-09-25 | 4 | BREY ROBERT N | SNGX | Stock Option (Right to Buy) | D | 0,68 | 35.000 | 35.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | HORGAN KEVIN | SNGX | Stock Option (Right to Buy) | D | 0,68 | 85.000 | 85.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Stock Option (Right to Buy) | D | 0,68 | 130.000 | 130.000 | |||||
| 2013-09-27 | 2013-09-25 | 4 | Warusz Joseph Michael | SNGX | Stock Option (Right to Buy) | D | 0,68 | 55.000 | 55.000 | |||||
| 2013-06-26 | 3 | INTREXON CORP by Intrexon Corporation | SNGX | Common Stock | I | 1.034.483 | ||||||||
| 2013-06-26 | 3 | INTREXON CORP by NRM VII Holdings | SNGX | Common Stock | I | 3.333.333 | ||||||||
| 2013-06-26 | 2013-06-25 | 4 | Brownlie Keith L | SNGX | Common Stock Warrants | D | 1,65 | 14.286 | 14.285 | |||||
| 2013-06-26 | 2013-06-25 | 4 | Brownlie Keith L | SNGX | Common Stock | D | 1,0500 | 19.047 | 20 | 19.047 | ||||
| 2013-06-26 | 2013-06-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock Warrants | D | 1,65 | 7.143 | 7.142 | |||||
| 2013-06-26 | 2013-06-25 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 1,0500 | 9.523 | 10 | 59.681 | ||||
| 2013-06-26 | 2013-06-25 | 4 | ZELDIS JEROME B | SNGX | Common Stock Warrants | D | 1,65 | 17.857 | 17.857 | |||||
| 2013-06-26 | 2013-06-25 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 1,0500 | 23.809 | 25 | 48.809 | ||||
| 2013-06-24 | 2013-06-20 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,30 | -25.000 | 0 | |||||
| 2013-06-24 | 2013-06-20 | 4 | ZELDIS JEROME B | SNGX | Common Stock | D | 0,3000 | 25.000 | 8 | 25.000 | ||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | CAVAZZA PAOLO Indirect | SNGX | Common Stock Warrant (warrant to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 0,53 | 1 | 1 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-12-21 | 2012-12-20 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 5,60 | -1 | 0 | |||||
| 2012-07-25 | 2012-06-21 | 4 | Brownlie Keith L | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | LAPOINTE ANTHONY GREGG | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | RUBIN ROBERT J. | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-07-25 | 2012-06-21 | 4 | ZELDIS JEROME B | SNGX | Stock Option (Right to Buy) | D | 0,30 | 25.000 | 25.000 | |||||
| 2012-04-11 | 2012-04-10 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 0,5098 | 9.900 | 5 | 50.157 | ||||
| 2012-01-18 | 2012-01-16 | 4 | SCHABER CHRISTOPHER J | SNGX | Common Stock | D | 333.333 | 805.150 | ||||||
| 2010-06-22 | 2010-06-18 | 4 | RUBIN ROBERT J. | SNGX | Common Stock | D | 0,2050 | 243.902 | 50 | 243.902 | ||||
| 2010-06-21 | 2010-06-18 | 4 | Essetifin SPA Indirect | SNGX | Common Stock Warrant (right to buy) | I | 0,28 | 1 | 1 | |||||
| 2010-06-21 | 2010-06-18 | 4 | Essetifin SPA Indirect | SNGX | Common Stock | I | 0,2050 | 8.608.580 | 1.765 | 54.227.816 | ||||
| 2009-09-28 | 2009-09-24 | 4 | Essetifin SPA Indirect | DORB | Common Stock Warrant (right to buy) | I | 0,28 | 1 | 1 | |||||
| 2009-09-28 | 2009-09-24 | 4 | Essetifin SPA Indirect | DORB | Common Stock | I | 0,2530 | 3.952.569 | 1.000 | 45.619.236 | ||||
| 2009-02-13 | 2009-02-11 | 4 | Essetifin SPA Indirect | DORB | Common Stock | I | 0,1800 | 25.000.000 | 4.500 | 41.666.667 | ||||
| 2008-12-03 | 3 | Leadiant Biosciences, Inc. Indirect | DORB | Common Stock | I | 16.666.667 | ||||||||
| 2007-07-02 | 3 | Buhrman Cyrille F | DORB | Common Stock | D | 4.900.020 | ||||||||
| 2007-07-02 | 2007-06-28 | 4 | Buhrman Cyrille F | DORB | Stock Options (right to buy) | D | 0,33 | 150.000 | 150.000 | |||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0100 | -875.300 | -884 | 162.600 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0200 | -248.700 | -254 | 1.037.900 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0300 | -68.200 | -70 | 1.286.600 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0400 | -51.300 | -53 | 1.354.800 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -12.600 | -13 | 1.406.100 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0700 | -33.200 | -36 | 1.418.700 | ||||
| 2004-02-18 | 2004-02-13 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0800 | -17.000 | -18 | 1.451.900 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0100 | -180.700 | -183 | 1.468.900 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0200 | -5.600 | -6 | 1.649.600 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0500 | -69.200 | -73 | 1.655.200 | ||||
| 2004-02-13 | 2004-02-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -11.000 | -12 | 1.724.400 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0500 | -106.900 | -112 | 1.735.400 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0600 | -44.900 | -48 | 1.842.300 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0700 | -4.800 | -5 | 1.887.200 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0800 | -16.600 | -18 | 1.892.000 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,0900 | -10.400 | -11 | 1.908.600 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,1000 | -81.000 | -89 | 1.919.000 | ||||
| 2004-02-13 | 2004-02-11 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 1,1100 | -52.879 | -59 | 2.000.000 | ||||
| 2004-02-06 | 2004-02-04 | 4 | ELAN CORP PLC I | DOR | Series B Convertible Preferred Stock | I | 5,11 | 126.567 | 126.567 | |||||
| 2004-02-06 | 2002-12-12 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 500.000 | 2.052.879 | ||||||
| 2004-02-06 | 2002-10-21 | 4 | ELAN CORP PLC I | DOR | Series C Convertible Preferred Stock | I | 8,86 | -110.323 | 0 | |||||
| 2004-02-06 | 2002-10-21 | 4 | ELAN CORP PLC I | DOR | Common Stock | I | 8,8600 | 1.245.187 | 11.032 | 1.552.879 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
